INTRODUCTION
1-Aryl-3-(2-chloroethyl)ureas (CEU S ) were found to exhibit better cytotoxicity 1 than the parent drugs i.e. chlorambucil and carmustine. [2] [3] [4] [5] [6] These derivatives as for examples 1-(4-tert-butylphenyl)-3-(2-chloroethyl) urea (A) and 1-(4-Iodophenyl)-3-(2-chloroethyl) urea (B) were designed as hybrid based on the conjugation of aromatic ring of chlorambucil as the prosthetic group and the cytotoxic 2-chloroethylnitrosourea moiety of carmustine as the pharmacophore. The SAR of the CEU derivatives showed that the unnitrosated derivatives were the only active ones; meanwhile, the exocyclic urea function and the 2-chloroethyl group were essential for activity; moreover, the preferred aryl groups were 4-substituted phenyl with alkyl or an indanyl group. 8 This class was found to irreversibly alkylate β-tubulin inside the cancer cell causing the cytotoxic effect. 9 Unfortunately, these derivatives caused many side effects such as developing resistance through P-glycoprotein overexpression and modification of topoisomerase I. 10 On the other side, a series of synthetic indole derivatives 11, 12 such as compound D-64131(C) have proven to have significant antitumoral activity both in vitro and in vivo. In our previous work, a series of benzamides (D) and 2-indolecarboamides (E) derivatives of the 4-(2-chloroethyl)semicarbazide were prepared 13 as a new class of cytotoxic agents. These derivatives were structurally related to 1-aryl-3-(2-chloroethyl) ureas derivatives with some structural variations whereas the aryl moiety whether p-substituted phenyl (D) or 5-substituted indolyl (E) was linked indirectly to (2-chloroethyl)urea function through carbonylamino moiety. It was found that semicarbazides containing 2-indolyl carbonyl moiety (E) especially those having electron-donor substituents at position 5 of the indole ring like methoxy (IC 50 = 8 µg/ml against U251) and benzyloxy (IC 50 = 21 µg/ml against Hepg2) showed a higher cytotoxic activity than their corresponding benzoyl derivatives(D) against human brain (U251) and liver (Hepg2)carcinoma cell lines.
In continuation to our previous work, a new series of hydrazone derivatives belonging to p-substituted benzaldehyde or p-substituted acetophenone were synthesized from 4-(2-chloroethyl) semicarbazide to study, firstly, the effect of different substituents on the cytotoxic activity. Secondly, we studied also the effect of replacement of p-substituted phenyl belonging to benzaldehyde hydrazone of the 4-(2-chloroethyl)semicarbazide by 5-substituted indolyl moieties upon the resultant cytotoxic activity against human brain and liver carcinoma cell lines.
Discussions

A) Chemisrty
To achieve the first aim, a new series of hydrazones derived from p-substituted benzaldehyde (2a-g) and p-substituted-acetophenone (3a-f) were prepared as shown in Scheme 1.
The novel and valuable key intermediate, 4-(2-chloroethyl) semicarbazide intermediate (1) , was prepared for the first time by adding 2-chloroethyl isocyanate dropwise to excess hydrazine hydrate in ethanol. Both the sequence of addition and room temperature were very important in order to minimize the formation of the expected side products. The intermediate 1 should be used directly in the next step, because it is very hygroscopic. Its structure was confirmed using the elemental analyses and mass spectroscopy.
The novel hydrazone derivatives of the 4-(2-chloroethyl)semicarbazide 2a-g or 3a-f were pre- The new compounds were characterized using melting points and thin layer chromatography techniques in different solvent systems. Moreover, the structures of the novel compounds were determined using elemental analyses and various spectral data. From the mass spectra, the absence of molecular ion peaks for compounds 2b, 4c, 4d and the appearance of M + -HCl (M + -36.5) peaks were observed, indicating the instability of molecular ion peak which undergoes rapid fragmentation and also the low relative intensity of such peak in some compounds such as 2a (3.8%) and 4b (5.9%).
The structure of some compounds as for example 4d which showed M + -36.5 peak in the mass spectra was established using 1 H-NMR. It confirmed the presence of straight chain for chloroethyl semicarbazide moiety through appearance of two peaks at various chemical shift 3.52 and 3.69 ppm for the two methylene groups as well as the appearance of two peaks at 6.78 and 10.05 ppm for the NH groups in addition to singlet peak at 8.07 ppm due to azomethine proton.
B) Cytotoxic evaluation
The new compounds 2a-g, 3a-f and 4a-d were evaluated for their in vitro cytotoxic activity against human brain (U251) and liver carcinoma (Hepg2) cell lines as well as their structure activity relationship (SAR) were studied. These targets were evaluated at four concentration values (10, 25, 50, 100 µg/ml) using the sulforhodamine B (SRB) assay 15 and the results were displayed in Table 1 . Given compounds were considered significantly active when their IC 50 values were lesser than 100 µg/ml. It was observed through analysis of table 1 that variable results were obtained depending not only on the type of the used cell line but also on the type of substitution at position 1 of the semicarbazides as seen in comparison of hydrazone derived from benzaldehyde (2a-g) with that of acetophenone (3a-f).
Firstly, regarding the U251 cell line, it could be concluded that cytotoxic activity has been increased in the order 3 < 2 as seen in comparison of the unsubstituted or methyl or chloro derivatives belonging to the general formulas 3 with that of 2.
Secondly, for Hepg2 cell line, the cytotoxic activity has increased in the order 2 < 3 as observed from IC 50 values for compounds 3e (6 ug/ml) and 3f (8 ug/ml) which showed the higher cytotoxic activity than their corresponding 2 derivatives. Table 1 revealed that replacement of phenyl ring of the parent compound 2a, (IC 50 = 35 ug/ml against U251 and 53 ug/ml against Hepg2) by indole moiety as seen in compound 4a, (IC 50 = 21 ug/ml against U251 and 7 ug/ml against Hepg2) led to an increase in the cytotoxic activity against the assigned cell lines. The last phenomena was also observed upon comparing the IC 50 values for compounds 2e, 2f which have an electron donating substituents with their corresponding indole derivatives 4c, 4d. Thus, hydrazones 4a, 4c, 4d containing an indole moiety were more active than their corresponding p-substituted phenyl derivatives.
It was also found that all chloro derivatives 2d, 3d and 4b have no cytotoxic activity upon Hepg2 which could arise from biochemical variations between different cancer cell phenotypes.
CONCLUSIONS
The main objective of this study was to synthesize new hydrazone derivatives of 4-(2-chloroethyl)semicarbazide and exploration of their potential cytotoxic activity.
SAR studies revealed that:
• Regarding human brain carcinoma cell line, the hydrazones of the 4-(2-chloroethyl)semicarbazide derived from p-substituted benzaldehyde especially derivative 2b exhibited the highest cytotoxic activity while in case of human liver carcinoma cell line, hydrazones 3e, 3f belonging to acetophenone gave the highest cytotoxic activity. • It could be concluded that replacement of p-substituted phenyl group of benzaldehyde hydrazones (2a, 2e, 2f) by indole moiety (4a, 4c, 4d) led to enhancement of the cytotoxic activity against the assigned cell lines.
• It was also found that semicarbazide 4a bearing an indole moiety was the most active one against the two cell lines and recommended for further future optimization to be potential candidate for new anticancer agents. General procedure for the preparation of 2a-g and 3a-f. To a solution of the appropriate carbonyl starting material (1 mmol) in EtOH (10 ml) and 10 drops glacial acetic acid was added equimolar amount of 1. The resulting mixture was stirred for 2 h then added to 50 mL ice-cold water. The resulting precipitate was filtered under vacuum, washed with water and finally crystallized from EtOH.
EXPERIMENTAL A) Chemistry Materials and Methods
2a. value was determined for each tumor cell line for the specified compound, calculated by an available computerized program, which was defined as the concentration of drug to produce a 50% reduction in the viability relative to the control and results were recorded in table 1.
